The creation of two significant medications, nazartinib and osimertinib medications, has been driven by the race in the realm of lung cancer therapy.Both drugs are precision therapies that zero in on unique genetic alterations within tumor cells to prevent their proliferation.A comparative study of nazartinib versus osimertinib becomes essential for patients and medical professionals to consider their choices, as it helps understand their unique characteristics, effectiveness, and ramifications for medical therapy.The first step in appreciating how nazartinib and osimertinib medications differ and which may be more suitable for a patient's…
